First human test for new celiac disease detection method begins
NCT ID NCT07063823
Summary
This is a very early safety study to test a potential new diagnostic tool called HB-2121 for celiac disease. Researchers will give a single dose to 18 adults (some with celiac disease, some healthy) and monitor them for 30 days to check for side effects and see how the body processes it. The main goal is to understand if this diagnostic approach is safe before further testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGStanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.